Methods of prevention of thromboembolic complications in patients with atrial fibrillation
- Authors: Patsenko M.B1,2, Steklov V.I3,2, Ivanov S.A4, Danilov Y.A4, Nugaeva N.R2
-
Affiliations:
- General Military Medical Directorate of the Ministry of Defense of the Russian Federation
- the S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation
- The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
- 12th Consultative and Diagnostic Center of the Ministry of Defense of the Russian Federation
- Issue: Vol 342, No 7 (2021)
- Pages: 15-25
- Section: Articles
- URL: https://journals.eco-vector.com/0026-9050/article/view/82602
- DOI: https://doi.org/10.52424/00269050_2021_342_7_15
- ID: 82602
Cite item
Abstract
Full Text
About the authors
M. B Patsenko
General Military Medical Directorate of the Ministry of Defense of the Russian Federation; the S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian FederationMoscow, Russia
V. I Steklov
The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation; the S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation
Email: vsteklov@yandex.ru
Moscow, Russia
S. A Ivanov
12th Consultative and Diagnostic Center of the Ministry of Defense of the Russian FederationMoscow, Russia
Yu. A Danilov
12th Consultative and Diagnostic Center of the Ministry of Defense of the Russian FederationMoscow, Russia
N. R Nugaeva
the S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian FederationMoscow, Russia
References
- Антитромботическая терапия в кардиологии / Под ред. Е.П.Панченко. - М.: Ремедиум, 2019. - 255 с.
- Евразийские клинические рекомендации по диагностике и лечению фибрилляции предсердий. - 2019. // URL: http://cardio-eur. asia/media/files/clinical_recommendations/recommendations_diagnosis_and_treatment_of _atrial_fibrillation_2019_rus.pdf (дата обращения: 22.02.2021).
- Кадырова М.В., Ильина М.В., Арбекова П.В., Степанова Ю.А. Чреспищеводная эхокардиография: методика, показания, возможности // Медицинская визуализация. - 2018. - Т. 22, № 2. - С. 25-46.
- Кобалава Ж.Д., Лазарев П.В., Федорова Д.Н. Когнитивная дисфункция на фоне фибрилляции предсердий: клинико-патогенетические ассоциации, диагностика и профилактика, аспекты применения антикоагулянтной терапии // Кардиология. - 2019. - Т. 59, № 10. - С. 66-77.
- Колбин А.С., Мосикян Б.А., Татарский Б.А. Социально-экономическое бремя фибрилляции предсердий в России: динамика за 7 лет (2010-2017 годы) // Вестн. аритмологии. - 2018. - № 92. - C. 42-48.
- Крайнюков П.Е., Серговенцев, А.А., Стеклов В.И. и др. Актуальные вопросы экспертизы профессиональной пригодности пациентов с высококурабельными аритмиями // Анналы аритмологии. - 2015. - Т. 12, № 3. - С. 174-182.
- Ревишвили А.Ш., Шляхто Е.В., Попов С.В. и др. Клинические рекомендации по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств. - М.: ВНОА, 2017. - 701 с.
- Фибрилляция и трепетание предсердий: Клинические рекомендации. - М., 2020. - 185 с.
- Филатов А.Г., Тарашвили Э.Г. Эпидемиология и социальная значимость фибрилляции предсердий // Анналы аритмологии. - 2012. - № 2. - С. 5-13.
- Baran J., Stec S., Pilichowska-Paszkiet E. et al. Intracardiac echocardioraphy for detection of thrombus in the left atrial appendage: comparison with transesophageal echocardiography in patients undergoing ablation for atrial fibrillation: the Action Ice I Study // Circ. Arrhythm. Electrophysiol. - 2013. - Vol. 6, N 6. - Р. 1074-1081.
- Bjоrck F., Renlund H., Lip G.Y. et al. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation // JAMA Cardiol. - 2016. - Vol. 1, N 2. - Р. 172-180.
- ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS // Europ. Heart J. - 2016. - Vol. 37, N 38. - Р. 2893-2962.
- Giannandrea D., Caponi C., Mengoni A. et al. Intravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic review // J. Neurol. Neurosurg. Psychiatry. - 2019. - Vol. 90, N 5. - Р. 619-623.
- Hansen M.L., Jepsen R.M., Olesen J.B. et al. Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy // Europace. - 2015. - Vol. 17, N 1. - Р. 18-23.
- Henrik V., Peter B.N., Sоren P.H. et al. Atrial flutter and thromboembolic risk: a systematic review // Heart. - 2015. - Vol. 101, N 18. - Р. 1446-1455.
- Hijazi Z., Oldgren J. Lindback J. et al. ARISTOTLE and RE-LY Investigators. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study // Lancet. - 2016. - Vol. 387, N 10035. - Р. 2302-2311.
- Hong K.S., Kwon S.U., Lee S.H. et al. Rivaroxaban vs Warfarin Sodium in the UltraEarly Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial // JAMA Neurol. - 2017. - Vol. 74, N 10. - Р. 1206-1215.
- Kim I.S., Kim H.J., Kim T.H. et al. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis // J. Cardiol. - 2018. - Vol. 72, N 4. - Р. 284-291.
- Koskinas K.C., Rаber L., Zanchin T. et al. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention // JACC Cardiovasc. Interv. - 2016. - Vol. 9, N 14. - Р. 1473-1483.
- Lopes R.D., Heizer G., Aronson R. et al. Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation // N. Engl. J. Med. - 2019. - Vol. 380, N 16. - Р. 1509-1524.
- Luigi D.B., David C., Karl G.H. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation // Europace. - 2017. - Vol. 19, N 1. - Р. 132-138.
- Murthy S.B., Gupta A., Merkler A.E. et al. Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis // Stroke. - 2017. - Vol. 48, N 6. - Р. 1594-1600.
- Noseworthy P.A., Yao X., Shah N.D., Gersh B.J. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease // Int. J. Cardiol. - 2016. - Vol. 209. - P. 181-183.
- Nuotio I., Hartikainen J.E., Gronberg T. et al. Time to cardioversion for acute atrial fibrillation and thromboembolic complications // JAMA. - 2014. - Vol. 312, N 6. - Р. 647-649.
- Pollack C.V. Coagulation assessment with the new generation of oral anticoagulants // Emerg. Med. J. - 2016. - Vol. 33, N 6. - Р. 423-430.
- Renda G., Ricci F., Giugliano R.P., De Caterina R. Non-Vitamin K Antagonist oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease // J. Am. Coll. Cardiol. - 2017. - Vol. 69, N 11. - Р. 1363-1371.
- Sticherling C., Marin F., Birnie D. et al. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS) // Europace. - 2015. - Vol. 17, N 8. - Р. 1197-1214.
- Van Laar C., Verberkmoes N.J., van Es H.W. et al. Thoracoscopic Left Atrial Appendage Clipping: A Multicenter Cohort Analysis // JACC Clin. Electrophysiol. - 2018. - Vol. 4, N 7. - Р. 893-901.